Skip to main content
SpringerLink
Log in
Book cover

Anti-inflammatory Nutraceuticals and Chronic Diseases pp 97–130Cite as

Tocotrienol and Its Role in Chronic Diseases

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 928))

Abstract

Tocotrienol is a member of vitamin E family and is well-known for its antioxidant and anti-inflammatory properties. It is also a suppressor of mevalonate pathway responsible for cholesterol and prenylated protein synthesis. This review aimed to discuss the health beneficial effects of tocotrienol, specifically in preventing or treating hyperlipidaemia, diabetes mellitus, osteoporosis and cancer with respect to these properties. Evidence from in vitro, in vivo and human studies has been examined. It is revealed that tocotrienol shows promising effects in preventing or treating the health conditions previously mentioned in in vivo and in vitro models. In some cases, alpha-tocopherol attenuates the biological activity of tocotrienol. Except for its cholesterol-lowering effects, data on the health-promoting effects of tocotrienol in human are limited. As a conclusion, the encouraging results on the health beneficial effects of tocotrienol should motivate researchers to explore its potential use in human.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Abd Manan N, Mohamed N, Shuid AN (2012) Effects of low-dose versus high-dose gamma-tocotrienol on the bone cells exposed to the hydrogen peroxide-induced oxidative stress and apoptosis. Evid Based Complement Altern Med 2012:680834

    Article  Google Scholar 

  2. Abdelmagid SM, Barbe MF, Safadi FF (2015) Role of inflammation in the aging bones. Life Sci 123:25–34

    Article  CAS  PubMed  Google Scholar 

  3. Abdul-Majeed S, Mohamed N, Soelaiman I-N (2012) Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Altern Med 2012:960742

    Article  Google Scholar 

  4. Abdul-Majeed S, Mohamed N, Soelaiman IN (2015) The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy. Life Sci 125:42–48

    Article  CAS  PubMed  Google Scholar 

  5. Abukhadir SSA, Mohamed N, Makpol S, Muhammad N (2012) Effects of palm vitamin e on bone-formation-related gene expression in nicotine-treated rats. Evid Based Complement Altern Med 2012:656025

    Article  Google Scholar 

  6. Aggarwal BB, Sundaram C, Prasad S, Kannappan R (2010) Tocotrienols, the vitamin E of the 21(St) Century: it’s potential against cancer and other chronic diseases. Biochem Pharmacol 80(11):1613–1631

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ahmad NS, Khalid BAK, Luke DA, Ima Nirwana S (2005) Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol 32(9):761–770

    Article  CAS  PubMed  Google Scholar 

  8. Aktifanus AT, Shuid AN, Rashid NH et al (2012) Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model. Asian J Anim Vet Adv 7(3):225–234

    Article  CAS  Google Scholar 

  9. Atli T, Keven K, Avci A et al (2004) oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Arch Gerontol Geriatr 39(3):269–275

    Article  CAS  PubMed  Google Scholar 

  10. Baek KH, Oh KW, Lee WY et al (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87(3):226–235

    Article  CAS  PubMed  Google Scholar 

  11. Baliarsingh S, Beg ZH, Ahmad J (2005) The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 182(2):367–374

    Article  CAS  PubMed  Google Scholar 

  12. Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205–214

    Article  CAS  PubMed  Google Scholar 

  13. Birringer M, EyTina JH, Salvatore BA, Neuzil J (2003) Vitamin E analogues as inducers of apoptosis: structure-function relation. Br J Cancer 88(12):1948–1955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A (2002) The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76(4):703–716

    CAS  PubMed  Google Scholar 

  15. Brooks R, Kalia P, Ireland DC, Beeton C, Rushton N (2011) Direct inhibition of osteoclast formation and activity by the vitamin E isomer gamma-tocotrienol. Int J Vitam Nutr Res 81(6):358–367

    Article  CAS  PubMed  Google Scholar 

  16. Budin SB, Othman F, Louis SR, Bakar MA, Das S, Mohamed J (2009) The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo) 64(3):235–244

    Article  Google Scholar 

  17. Buhaescu I, Izzedine H (2007) Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 40(9–10):575–584

    Article  CAS  PubMed  Google Scholar 

  18. Burdeos GC, Nakagawa K, Kimura F, Miyazawa T (2012) Tocotrienol attenuates triglyceride accumulation in Hepg2 cells and F344 rats. Lipids 47(5):471–481

    Article  CAS  PubMed  Google Scholar 

  19. Burdeos GC, Nakagawa K, Watanabe A, Kimura F, Miyazawa T (2013) Gamma-tocotrienol attenuates triglyceride through effect on lipogenic gene expressions in mouse hepatocellular carcinoma hepa 1-6. J Nutr Sci Vitaminol (Tokyo) 59(2):148–151

    Article  CAS  Google Scholar 

  20. Callaway DA, Jiang JX (2015) Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. J Bone Miner Metab 33(4):359–370

    Article  CAS  PubMed  Google Scholar 

  21. Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM (2012) Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 35(9):1835–1844

    Article  PubMed  PubMed Central  Google Scholar 

  22. Chang PN, Yap WN, Lee DT, Ling MT, Wong YC, Yap YL (2009) Evidence of Γ-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr Cancer 61(3):357–366

    Article  CAS  PubMed  Google Scholar 

  23. Chatelain E, Boscoboinik DO, Bartoli G-M et al (1993) Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta (BBA) Mol Cell Res 1176(1–2):83–89

    Article  CAS  Google Scholar 

  24. Chin K-Y, Ima-Nirwana S (2012) Vitamin E as an antiosteoporotic agent via receptor activator of nuclear factor kappa-B ligand signaling disruption: current evidence and other potential research areas. Evid Based Complement Altern Med 2012:747020

    Article  Google Scholar 

  25. Chin KY, Abdul-Majeed S, Fozi NF, Ima-Nirwana S (2014) Annatto tocotrienol improves indices of bone static histomorphometry in osteoporosis due to testosterone deficiency in rats. Nutrients 6(11):4974–4983

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Chin KY, Ima-Nirwana S (2014) The effects of alpha-tocopherol on bone: a double-edged sword? Nutrients 6(4):1424–1441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chin KY, Ima-Nirwana S (2015) the biological effects of tocotrienol on bone: a review on evidence from rodent models. Drug Des Devel Ther 9:2049–2061

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chin KY, Ima Nirwana S (2014) The effects of annatto-derived tocotrienol supplementation in osteoporosis induced by testosterone deficiency in rats. Clin Interv Aging 9:1247–1259

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Chin SF, Ibahim J, Makpol S et al (2011) Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: a randomized controlled study. Nutr Metab (Lond) 8(1):42

    Article  CAS  Google Scholar 

  30. Choy EHS, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907–916

    Article  CAS  PubMed  Google Scholar 

  31. Chun J, Lee J, Ye L, Exler J, Eitenmiller RR (2006) Tocopherol and tocotrienol contents of raw and processed fruits and vegetables in the United States Diet. J Food Compos Anal 19(2–3):196–204

    Article  CAS  Google Scholar 

  32. Comitato R, Nesaretnam K, Leoni G et al (2009) A novel mechanism of natural vitamin E tocotrienol activity: involvement of Erβ signal transduction. Am J Physiol Endocrinol Metab 297:E427–E437

    Article  CAS  PubMed  Google Scholar 

  33. Constantinou C, Hyatt JA, Vraka PS et al (2009) Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives. Nutr Cancer 61(6):864–874

    Article  CAS  PubMed  Google Scholar 

  34. Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F (2004) Γ-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann N Y Acad Sci 1031:391–394

    Article  CAS  PubMed  Google Scholar 

  35. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25(1):4–7

    Article  CAS  PubMed  Google Scholar 

  36. Daud ZA, Tubie B, Sheyman M et al (2013) Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag 9:747–761

    PubMed  PubMed Central  Google Scholar 

  37. Deng L, Ding Y, Peng Y et al (2014) Γ-tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as Hmg-Coa reductase inhibitor. Bone 67:200–207

    Article  CAS  PubMed  Google Scholar 

  38. Deshpande AD, Harris-Hayes M, Schootman M (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88(11):1254–1264

    Article  PubMed  PubMed Central  Google Scholar 

  39. Di Marco E, Jha JC, Sharma A, Wilkinson-Berka JL, Jandeleit-Dahm KA, de Haan JB (2015) Are reactive oxygen species still the basis for diabetic complications? Clin Sci (Lond) 129(2):199–216

    Article  CAS  Google Scholar 

  40. Eitsuka T, Nakagawa K, Miyazawa T (2006) Down-regulation of telomerase activity in Dld-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem Biophys Res Commun 348(1):170–175

    Article  CAS  PubMed  Google Scholar 

  41. Elangovan S, Hsieh TC, Wu JM (2008) Growth inhibition of human Mda-Mb-231 breast cancer cells by Δ-tocotrienol is associated with loss of cyclin D1/Cdk4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res 28:2641–2648

    CAS  PubMed  Google Scholar 

  42. Frega N, Mozzon M, Bocci F (1998) Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography-mass spectrometry. J Am Oil Chem Soc 75(12):1723–1727

    Article  CAS  Google Scholar 

  43. Gee PT (2011) Unleashing the untold and misunderstood observations on vitamin E. Genes Nutr 6(1):5–16

    Article  CAS  PubMed  Google Scholar 

  44. Guthrie N, Gapor A, Chambers AF, Carroll KK (1997) Inhibition of proliferation of estrogen receptor-negative Mda-Mb-435 and -Positive Mcf-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 127:544S–548S

    CAS  PubMed  Google Scholar 

  45. Guthrie N, Gapor A, Chambers AF, Carroll KK (1997) Palm oil tocotrienols and plant flavonoids act synergistically with each other and with tamoxifen in inhibiting proliferation and growth of estrogen receptor-negative Mda-Mb-435 and -positive Mcf-7 human breast cancer cells in culture. Asia Pac J Clin Nutrition 6(1):41–45

    CAS  Google Scholar 

  46. Ha H, Lee JH, Kim HN, Lee ZH (2011) Alpha-tocotrienol inhibits osteoclastic bone resorption by suppressing rankl expression and signaling and bone resorbing activity. Biochem Biophys Res Commun 406(4):546–551

    Article  CAS  PubMed  Google Scholar 

  47. Haghighat N, Vafa M, Eghtesadi S, Heidari I, Hosseini A, Rostami A (2014) The effects of tocotrienols added to canola oil on microalbuminuria, inflammation, and nitrosative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Int J Prev Med 5(5):617–623

    PubMed  PubMed Central  Google Scholar 

  48. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344(8924):721–724

    Article  CAS  PubMed  Google Scholar 

  49. Har CH, Keong CK (2005) Effects of tocotrienols on cell viability and apoptosis in normal murine liver cells (Bnl Cl.2) and liver cancer cells (Bnl 1me A.7r.1), in Vitro. Asia Pac J Clin Nutr 14(4):374–380

    CAS  PubMed  Google Scholar 

  50. Heng KS, Hejar AR, Johnson Stanslas J, Ooi CF, Loh SF (2015) Potential of mixed tocotrienol supplementation to reduce cholesterol and cytokines level in adults with metabolic syndrome. Malays J Nutr 21(2):231–243

    Google Scholar 

  51. Hermizi H, Faizah O, Ima-Nirwana S, Ahmad Nazrun S, Norazlina M (2009) Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcif Tissue Int 84(1):65–74

    Article  CAS  PubMed  Google Scholar 

  52. Hiura Y, Tachibana H, Arakawa R et al (2009) Specific accumulation of Γ- and Δ-tocotrienols in tumor and their antitumor effect in vivo. J Nutr Biochem 20(8):607–613

    Article  CAS  PubMed  Google Scholar 

  53. Hosomi A, Arita M, Sato Y et al (1997) Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409(1):105–108

    Article  CAS  PubMed  Google Scholar 

  54. Hsieh TC, Wu JM (1992) Suppression of cell proliferation and gene expression by combinatorial synergy of Egcg, resveratrol and Γ-tocotrienol in estrogen receptor-positive Mcf-7 breast cancer cells. Int J Oncol 33(4):851–859

    Article  CAS  Google Scholar 

  55. Husain K, Francois RA, Hutchinson SZ et al (2009) Vitamin E Δ-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration. Pharmacology 83(3):157–163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ima-Nirwana S, Fakhrurazi H (2002) Palm vitamin E protects bone against dexamethasone-induced osteoporosis in male rats. Med J Malaysia 57(2):133–141

    Google Scholar 

  57. Ima-Nirwana S, Nurshazwani Y, Nazrun AS, Norliza M, Norazlina M (2011) Subacute and subchronic toxicity studies of palm vitamin E in mice. J Pharmacol Toxicol 6:166–173

    Article  CAS  Google Scholar 

  58. Ima Nirwana S, Kiftiah A, Zainal A, Norazlina M, Abd. Gapor M, Khalid BAK (2000) Palm vitamin E prevents osteoporosis in orchidectomised growing male rats. Nat Prod Sci 6(4):155–160

    CAS  Google Scholar 

  59. Ima Nirwana S, Suhaniza S (2004) Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J Med Food 7(1):45–51

    Article  CAS  PubMed  Google Scholar 

  60. Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M, Miyazawa T (2003) Anti-angiogenic activity of tocotrienol. Biosci Biotechnol Biochem 67(7):1623–1627

    Article  CAS  PubMed  Google Scholar 

  61. Institute of Medicine (2000) Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. The National Academies Press, Washington

    Google Scholar 

  62. Iqbal J, Minhajuddin M, Beg ZH (2003) Suppression of 7,12-dimethylbenz[alpha]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J Cancer Prev 12(6):447–453

    Article  CAS  PubMed  Google Scholar 

  63. Jiang Q (2014) Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 72:76–90

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Johnell O, Kanis J (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733

    Article  CAS  PubMed  Google Scholar 

  65. Jones MP, Pandak WM, Heuman DM, Chiang JY, Hylemon PB, Vlahcevic ZR (1993) Cholesterol 7 alpha-hydroxylase: evidence for transcriptional regulation by cholesterol or metabolic products of cholesterol in the rat. J Lipid Res 34(6):885–892

    CAS  PubMed  Google Scholar 

  66. Kamat JP, Devasagayam TP (1995) Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett 195(3):179–182

    Article  CAS  PubMed  Google Scholar 

  67. Kamat JP, Sarma HD, Devasagayam TP, Nesaretnam K, Basiron Y (1997) Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol Cell Biochem 170(1–2):131–137

    Article  CAS  PubMed  Google Scholar 

  68. Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD (2015) Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res 30(10):1747–1753

    Article  PubMed  Google Scholar 

  69. Kashiwagi K, Harada K, Yano Y et al (2008) A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells. Biochem Biophys Res Commun 365(4):875–881

    Article  CAS  PubMed  Google Scholar 

  70. Kashiwagi K, Virgona N, Harada K et al (2009) A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells. Life Sci 84(19–20):650–656

    Article  CAS  PubMed  Google Scholar 

  71. Kataja-Tuomola MK, Kontto JP, Mannisto S, Albanes D, Virtamo J (2011) Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr 65(5):590–597

    Article  CAS  PubMed  Google Scholar 

  72. Kawakami Y, Tsuzuki T, Nakagawa K, Miyazawa T (2007) Distribution of tocotrienols in rats fed a rice bran tocotrienol concentrate. Biosci Biotechnol Biochem 71(2):464–471

    Article  CAS  PubMed  Google Scholar 

  73. Khor H, Ng T, Rajendran R (2002) Dose-dependent cholesterolemic activity of tocotrienols. Malays J Nutr 8(2):157–166

    PubMed  Google Scholar 

  74. Khor HT, Ng TT (2000) Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver Hmg Coa reductase activity. Int J Food Sci Nutr 51(Suppl):S3–S11

    Article  CAS  PubMed  Google Scholar 

  75. King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166(3):877–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Kuhad A, Bishnoi M, Tiwari V, Chopra K (2009) Suppression of Nf-Kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 92(2):251–259

    Article  CAS  PubMed  Google Scholar 

  77. Kuhad A, Chopra K (2009) Attenuation of diabetic nephropathy by tocotrienol: involvement of Nfkb signaling pathway. Life Sci 84(9–10):296–301

    Article  CAS  PubMed  Google Scholar 

  78. Kuhad A, Chopra K (2009) Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 57(4):456–462

    Article  CAS  PubMed  Google Scholar 

  79. Lee SP, Mar GY, Ng LT (2009) Effects of tocotrienol-rich fraction on exercise endurance capacity and oxidative stress in forced swimming rats. Eur J Appl Physiol 107(5):587–595

    Article  CAS  PubMed  Google Scholar 

  80. Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83(2):456S–460S

    CAS  PubMed  Google Scholar 

  81. Lodge JK, Ridlington J, Leonard S, Vaule H, Traber MG (2001) Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 36(1):43–48

    Article  CAS  PubMed  Google Scholar 

  82. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25(1):29–38

    CAS  PubMed  Google Scholar 

  83. Maniam S, Mohamed N, Shuid AN, Soelaiman IN (2008) Palm tocotrienol exerted better antioxidant activities in bone than α-tocopherol. Basic Clin Pharmacol Toxicol 103(1):55–60

    Article  CAS  PubMed  Google Scholar 

  84. Manolagas SC (2010) From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis. Endocr Rev 31(3):266–300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Matough FA, Budin SB, Hamid ZA, Abdul-Rahman M, Al-Wahaibi N, Mohammed J (2014) Tocotrienol-rich fraction from palm oil prevents oxidative damage in diabetic rats. Sultan Qaboos Univ Med J 14(1):e95–e103

    Article  PubMed  PubMed Central  Google Scholar 

  86. McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H (2007) Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood) 232:523–531

    CAS  Google Scholar 

  87. McIntyre BS, Briski KP, Gapor A, Sylvester PW (2008) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224(4):292–301

    Article  Google Scholar 

  88. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35(2):171–180

    Article  CAS  PubMed  Google Scholar 

  89. Mehat M, Shuid A, Mohamed N, Muhammad N, Soelaiman I (2010) Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats. J Bone Miner Metab 28(5):503–509

    Article  CAS  PubMed  Google Scholar 

  90. Mensink RP, van Houwelingen AC, Kromhout D, Hornstra G (1999) A Vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 69(2):213–219

    CAS  PubMed  Google Scholar 

  91. Minhajuddin M, Beg ZH, Iqbal J (2005) Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem Toxicol 43(5):747–753

    Article  CAS  PubMed  Google Scholar 

  92. Miyazawa T, Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M (2004) Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Moscow) 69(1):67–69

    Article  CAS  Google Scholar 

  93. Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T (2008) Anti-angiogenic function of tocotrienol. Asia Pac J Clin Nutr 17(S1):253–256

    CAS  PubMed  Google Scholar 

  94. Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M (2004) Antiangiogenic potency of vitamin E. Ann N Y Acad Sci 1031:401–404

    Article  CAS  PubMed  Google Scholar 

  95. Mizushina Y, Nakagawa K, Shibata A et al (2006) Inhibitory effect of tocotrienol on eukaryotic DNA polymerase Λ and angiogenesis. Biochem Biophys Res Commun 339(3):949–955

    Article  CAS  PubMed  Google Scholar 

  96. Muhammad N, Luke DA, Shuid AN, Mohamed N, Soelaiman IN (2012) Two different isomers of vitamin E prevent bone loss in postmenopausal osteoporosis rat model. Evid Based Complement Altern Med 2012:161527

    Article  Google Scholar 

  97. Muhammad N, Razali S, Shuid AN, Mohamed N, Soelaiman IN (2013) Membandingkan Kesan Antara Fraksi-Kaya Tokotrienol, Kalsium Dan Estrogen Terhadap Metabolisme Tulang Tikus Terovariektomi. Sains Malays 42(11):1591–1597

    CAS  Google Scholar 

  98. Müller M, Cela J, Asensi-Fabado MA, Munné-Bosch S (2012) Tocotrienols in plants: occurrence, biosynthesis, and function. In: Tan B, Watson RR, Preedy VR (eds) Tocotrienols: vitamin E beyond tocopherols. CRC Press, Florida, pp 1–16

    Google Scholar 

  99. Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(suppl 3):S147–S151

    Article  PubMed  Google Scholar 

  100. Munteanu A, Ricciarelli R, Massone S, Zingg JM (2007) Modulation of proteasome activity by vitamin E in Thp-1 monocytes. IUBMB Life 59(12):771–780

    Article  CAS  PubMed  Google Scholar 

  101. Mustad VA, Smith CA, Ruey PP, Edens NK, DeMichele SJ (2002) Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 76(6):1237–1243

    CAS  PubMed  Google Scholar 

  102. Naito Y, Shimozawa M, Kuroda M et al (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180(1):19–25

    Article  CAS  PubMed  Google Scholar 

  103. Nakagawa K, Shibata A, Yamashita S et al (2007) In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol. J Nutr 137:1938–1943

    CAS  PubMed  Google Scholar 

  104. Nakamura H, Furukawa F, Nishikawa A et al (2001) Oral toxicity of a tocotrienol preparation in rats. Food Chem Toxicol 39(8):799–805

    Article  CAS  PubMed  Google Scholar 

  105. Nazrun AS, Luke DA, Khalid BAK, Ima Nirwana S (2005) Vitamin E protects from free-radical damage on femur of rats treated with ferric nitrilotriacetate. Curr Topics Pharmacol 9(2):107–115

    CAS  Google Scholar 

  106. Nesaretnam K, Devasagayam TP, Singh BB, Basiron Y (1993) Influence of palm oil or its tocotrienol-rich fraction on the lipid peroxidation potential of rat liver mitochondria and microsomes. Biochem Mol Biol Int 30(1):159–167

    CAS  PubMed  Google Scholar 

  107. Nesaretnam K, Meganathan P, Veerasenan SD, Selvaduray KR (2012) Tocotrienols and breast cancer: the evidence to date. Genes Nutr 7(1):3–9

    Article  CAS  PubMed  Google Scholar 

  108. Nesaretnam K, Selvaduray KR, Abdul Razak G, Veerasenan SD, Gomez PA (2010) Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial. Breast Cancer Res 12(5):R81

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  109. Nesaretnam K, Stephen R, Dils R, Darbre P (1998) Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33(5):461–469

    Article  CAS  PubMed  Google Scholar 

  110. Ng LT, Ko HJ (2012) Comparative effects of tocotrienol-rich fraction, alpha-tocopherol and alpha-tocopheryl acetate on inflammatory mediators and nuclear factor kappa B expression in mouse peritoneal macrophages. Food Chem 134(2):920–925

    Article  CAS  PubMed  Google Scholar 

  111. Ng MH, Choo YM, Ma AN, Chuah CH, Hashim MA (2004) Separation of vitamin E (tocopherol, tocotrienol, and tocomonoenol) in palm oil. Lipids 39(10):1031–1035

    Article  CAS  PubMed  Google Scholar 

  112. Ngah WZW, Jarien Z, San MM et al (1991) Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am J Clin Nutr 53:1076S–1081S

    CAS  PubMed  Google Scholar 

  113. Niki E (2013) Antioxidant action of tocotrienols. In: Tan B, Watson RR, Preedy VR (eds) Tocotrienols: vitamin E beyond tocopherols. CRC Press, Boca Raton, pp 233–240

    Google Scholar 

  114. Nikolic K, Agababa D (2009) Design and Qsar study of analogs of Γ-tocotrienol with enhanced antiproliferative activity against human breast cancer cells. J Mol Graph Model 27(7):777–783

    Article  CAS  PubMed  Google Scholar 

  115. Nizar AM, Nazrun AS, Norazlina M, Norliza M, Ima Nirwana S (2011) Low dose of tocotrienols protects osteoblasts against oxidative stress. Clin Ter 162(6):533–538

    CAS  PubMed  Google Scholar 

  116. Noguchi N, Hanyu R, Nonaka A, Okimoto Y, Kodama T (2003) Inhibition of Thp-1 cell adhesion to endothelial cells by Α-tocopherol and Α-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34(12):1614–1620

    Article  CAS  PubMed  Google Scholar 

  117. Norazlina M, Hermizi H, Faizah O, Ima-Nirwana S (2010) Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats. Arch Med Sci 6(4):505–512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Norazlina M, Ima Nirwana S, Abd. Gapor M, Khalid B (2000) Palm vitamin E is comparable to alpha-tocotrienol in maintaining bone mineral density in ovariectomised female rats. Exp Clin Endocrinol Diabetes 108:305–310

    Article  CAS  PubMed  Google Scholar 

  119. Norazlina M, Lee P, Lukman H, Nazrun A, Ima-Nirwana S (2007) Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats. Singapore Med J 48(3):195–199

    CAS  PubMed  Google Scholar 

  120. O’Byrne D, Grundy S, Packer L et al (2000) Studies of Ldl oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 29(9):834–845

    Article  PubMed  Google Scholar 

  121. Palozza P, Verdecchia S, Avanzi L et al (2006) Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule feaox-6 in isolated membranes and intact cells. Mol Cell Biochem 287(1–2):21–32

    Article  CAS  PubMed  Google Scholar 

  122. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ (1993) Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. J Biol Chem 268(15):11230–11238

    CAS  PubMed  Google Scholar 

  123. Patel J, Matnor NA, Iyer A, Brown L (2011) A regenerative antioxidant protocol of vitamin E and alpha-lipoic acid ameliorates cardiovascular and metabolic changes in fructose-fed rats. Evid Based Complement Altern Med 2011:120801

    Article  Google Scholar 

  124. Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE (1996) Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in chickens. J Nutr 126(2):389–394

    CAS  PubMed  Google Scholar 

  125. Qureshi AA, Peterson DM (2001) The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis 156(1):39–47

    Article  CAS  PubMed  Google Scholar 

  126. Qureshi AA, Peterson DM, Hasler-Rapacz JO, Rapacz J (2001) Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 131(2):223–230

    CAS  PubMed  Google Scholar 

  127. Qureshi AA, Qureshi N, Hasler-Rapacz JO et al (1991) Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 53(4 Suppl):1042s–1046s

    CAS  PubMed  Google Scholar 

  128. Qureshi AA, Qureshi N, Wright JJ et al (1991) Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvitee). Am J Clin Nutr 53(4 Suppl):1021s–1026s

    CAS  PubMed  Google Scholar 

  129. Qureshi AA, Reis JC, Papasian CJ, Morrison DC, Qureshi N (2010) Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids Health Dis 9:143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Qureshi AA, Reis JC, Qureshi N, Papasian CJ, Morrison DC, Schaefer DM (2011) Delta-tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis 10:39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Qureshi AA, Sami SA, Salser WA, Khan FA (2001) Synergistic effect of tocotrienol-rich fraction (Trf(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 12(6):318–329

    Article  CAS  PubMed  Google Scholar 

  132. Qureshi AA, Sami SA, Salser WA, Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (Trf25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161(1):199–207

    Article  CAS  PubMed  Google Scholar 

  133. Qureshi AA, Tan X, Reis JC et al (2011) Inhibition of nitric oxide in Lps-stimulated macrophages of young and senescent mice by delta-tocotrienol and quercetin. Lipids Health Dis 10:239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Raederstorff D, Elste V, Aebischer C, Weber P (2002) Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann Nutr Metab 46(1):17–23

    Article  CAS  PubMed  Google Scholar 

  135. Rahmat A, Ngah WZW, Top AGM, Khalid BAK (1993) Long term tocotrienol supplementation and glutathione-dependent enzymes during hepatocarcinogenesis in the rat. Asia Pac J Clin Nutr 2:129–134

    CAS  PubMed  Google Scholar 

  136. Rasool AH, Yuen KH, Yusoff K, Wong AR, Rahman AR (2006) Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol (Tokyo) 52(6):473–478

    Article  CAS  Google Scholar 

  137. Rasool AHG, Yuen KH, Yusoff K, Wong AR, Rahman ARA (2006) Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol 52:473–478

    Article  CAS  PubMed  Google Scholar 

  138. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659–661

    Article  CAS  PubMed  Google Scholar 

  139. Rickmann M, Vaquero EC, Malagelada JR, Molero X (2007) Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology 132(7):2518–2532

    Article  CAS  PubMed  Google Scholar 

  140. Sakai M, Okabe M, Tachibana H, Yamada K (2006) Apoptosis induction by Γ-tocotrienol in human hepatoma Hep3b cells. J Nutr Biochem 17(10):672–676

    Article  CAS  PubMed  Google Scholar 

  141. Sakai M, Okabe M, Yamasaki A, Tachibana H, Yamada K (2004) Induction of apoptosis by tocotrienol in rat hepatoma Drlh-84 cells. Anticancer Res 24:1683–1688

    CAS  PubMed  Google Scholar 

  142. Salman Khan M, Akhtar S, Al-Sagair OA, Arif JM (2011) Protective effect of dietary tocotrienols against infection and inflammation-induced hyperlipidemia: an in vivo and in silico study. Phytother Res PTR 25(11):1586–1595

    Article  CAS  PubMed  Google Scholar 

  143. Samant GV, Sylvester PW (2006) Γ-tocotrienol inhibits Erbb3-dependent Pi3k-Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Prolif 39:563–574

    Article  CAS  PubMed  Google Scholar 

  144. Sen CK, Khanna S, Roy S, Packer L (2000) Molecular basis of vitamin E action: tocotrienol potently inhibits glutamate-induced Pp60c-Src kinase activation and death of Ht4 neuronal cells. J Biol Chem 275(17):13049–13055

    Article  CAS  PubMed  Google Scholar 

  145. Serbinova E, Kagan V, Han D, Packer L (1991) Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 10(5):263–275

    Article  CAS  PubMed  Google Scholar 

  146. Shah SJ, Sylvester PW (2005) Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem Cell Biol 83(1):86–95

    Article  CAS  PubMed  Google Scholar 

  147. Shibata A, Nakagawa K, Shirakawa H et al (2012) Physiological effects and tissue distribution from large doses of tocotrienol in rats. Biosci Biotechnol Biochem 76(9):1805–1808

    Article  CAS  PubMed  Google Scholar 

  148. Shibata A, Nakagawa K, Sookwong P et al (2008) Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1α. J Nutr 138(11):2136–2142

    Article  CAS  PubMed  Google Scholar 

  149. Shuid A, Mehat Z, Mohamed N, Muhammad N, Soelaiman I (2010) Vitamin E exhibits bone anabolic actions in normal male rats. J Bone Miner Metab 28(2):149–156

    Article  CAS  PubMed  Google Scholar 

  150. Siddiqui S, Ahsan H, Khan MR, Siddiqui WA (2013) Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in Tgf-beta expression. Toxicol Appl Pharmacol 273(2):314–324

    Article  CAS  PubMed  Google Scholar 

  151. Siddiqui S, Rashid Khan M, Siddiqui WA (2010) Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (Trf) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem Biol Interact 188(3):651–658

    Article  CAS  PubMed  Google Scholar 

  152. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82(2):291–295

    Article  CAS  PubMed  Google Scholar 

  153. Sies H (2000) What is oxidative stress? In: Keaney J, Jr. (ed) Oxidative stress and vascular disease. Developments in cardiovascular medicine, vol 224. Springer, New York , pp 1–8

    Google Scholar 

  154. Soelaiman IN, Ming W, Abu Bakar R et al (2012) Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats. Int J Endocrinol 2012:532862

    Article  PubMed  PubMed Central  Google Scholar 

  155. Song BL, DeBose-Boyd RA (2006) Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem 281(35):25054–25061

    Article  CAS  PubMed  Google Scholar 

  156. Sookwong P, Nakagawa K, Murata K, Kojima Y, Miyazawa T (2007) Quantitation of tocotrienol and tocopherol in various rice brans. J Agric Food Chem 55(2):461–466

    Article  CAS  PubMed  Google Scholar 

  157. Sookwong P, Nakagawa K, Yamaguchi Y et al (2010) Tocotrienol distribution in foods: estimation of daily tocotrienol intake of Japanese population. J Agric Food Chem 58(6):3350–3355

    Article  CAS  PubMed  Google Scholar 

  158. Srivastava JK, Gupta S (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346(2):447–453

    Article  CAS  PubMed  Google Scholar 

  159. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284(3):311–318

    Article  CAS  PubMed  Google Scholar 

  160. Sun W, Xu W, Liu H et al (2009) Γ-tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma Sgc-7901 cells. J Nutr Biochem 20(4):276–284

    Article  CAS  PubMed  Google Scholar 

  161. Suzuki YJ, Tsuchiya M, Wassall SR et al (1993) Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32(40):10692–10699

    Article  CAS  PubMed  Google Scholar 

  162. Sylvester PW, Nachnani A, Shah S, Briski KP (2002) Role of Gtp-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr 11(Suppl):S452–S459

    Article  CAS  PubMed  Google Scholar 

  163. Sylvester PW, Shah S (2005) Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J Clin Nutr 14(4):366–373

    CAS  PubMed  Google Scholar 

  164. Sylvester PW, Shah SJ (2005) Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front Biosci 10(1–3):699

    Article  CAS  PubMed  Google Scholar 

  165. Takahashi K, Loo G (2004) Disruption of mitochondria during tocotrienol-induced apoptosis in Mda-Mb-231 human breast cancer cells. Biochem Pharmacol 67(2):315–324

    Article  CAS  PubMed  Google Scholar 

  166. Tan CY, Saw TY, Fong CW, Ho HK (2015) Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury. Redox Biol 4:308–320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  167. Tan DT, Khor HT, Low WH, Ali A, Gapor A (1991) Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am J Clin Nutr 53(4 Suppl):1027s–1030s

    CAS  PubMed  Google Scholar 

  168. Theriault A, Wang Q, Gapor A, Adeli K (1999) Effects of gamma-tocotrienol on apob synthesis, degradation, and secretion in Hepg2 cells. Arterioscler Thromb Vasc Biol 19(3):704–712

    Article  CAS  PubMed  Google Scholar 

  169. Tomeo AC, Geller M, Watkins TR, Gapor A, Bierenbaum ML (1995) Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30(12):1179–1183

    Article  CAS  PubMed  Google Scholar 

  170. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84

    Article  CAS  PubMed  Google Scholar 

  171. Vester H, Holzer N, Neumaier M, Lilianna S, Nussler AK, Seeliger C (2014) Green tea extract (Gte) improves differentiation in human osteoblasts during oxidative stress. J Inflamm (Lond) 11:15

    Article  CAS  Google Scholar 

  172. Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H (2005) Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett 229(2):181–191

    Article  CAS  PubMed  Google Scholar 

  173. Wali VB, Bachawal SV, Sylvester PW (2009) Endoplasmic reticulum stress mediates Γ-tocotrienol-induced apoptosis in mammary tumor cells. Apoptosis 14(11):1366–1377

    Article  CAS  PubMed  Google Scholar 

  174. Wali VB, Bachawal SV, Sylvester PW (2009) Suppression in mevalonate synthesis mediates antitumor effects of combined statin and Γ-tocotrienol treatment. Lipids 44(10):925–934

    Article  CAS  PubMed  Google Scholar 

  175. Wali VB, Sylvester PW (2007) Synergistic antiproliferative effects of Γ-tocotrienol and statin treatment on mammary tumor cells. Lipids 42(12):1113–1123

    Article  CAS  PubMed  Google Scholar 

  176. Wan Nazaimoon WM, Khalid BA (2002) Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays J Pathol 24(2):77–82

    CAS  PubMed  Google Scholar 

  177. Wang Y, Jiang Q (2013) Gamma-tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/Ebpbeta and Nf-Kappab in macrophages. J Nutr Biochem 24(6):1146–1152

    Article  CAS  PubMed  Google Scholar 

  178. Wang Y, Park NY, Jang Y, Ma A, Jiang Q (2015) Vitamin E gamma-tocotrienol inhibits cytokine-stimulated Nf-kappab activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids. J Immunol 195(1):126–133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  179. Watkins T, Lenz P, Gapor A, Struck M, Tomeo A, Bierenbaum M (1993) Gamma-tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28(12):1113–1118

    Article  CAS  PubMed  Google Scholar 

  180. Weng-Yew W, Selvaduray KR, Ming CH, Nesaretnam K (2009) Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr Cancer 61(3):367–373

    Article  PubMed  CAS  Google Scholar 

  181. Wu SJ, Liu PL, Ng LT (2008) Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res 52(8):921–929

    Article  CAS  PubMed  Google Scholar 

  182. Xu WL, Liu JR, Liu HK et al (2009) Inhibition of proliferation and induction of apoptosis by Γ-tocotrienol in human colon carcinoma Ht-29 cells. Nutrition 25(5):555–566

    Article  CAS  PubMed  Google Scholar 

  183. Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K (2009) Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in Raw264.7 macrophages. Lipids 44(9):787–789

    Article  CAS  PubMed  Google Scholar 

  184. Yano Y, Satoh H, Fukumoto K et al (2005) Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-Α-tocotrienol, a redox-silent derivative of Α-tocotrienol. Int J Cancer 115(5):839–846

    Article  CAS  PubMed  Google Scholar 

  185. Yap SP, Yuen KH, Wong JW (2001) Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53(1):67–71

    Article  CAS  PubMed  Google Scholar 

  186. Yoshida Y, Hayakawa M, Habuchi Y, Itoh N, Niki E (2007) Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane. Lipids 42(5):463–472

    Article  CAS  PubMed  Google Scholar 

  187. Yoshida Y, Niki E, Noguchi N (2003) Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 123(1):63–75

    Article  CAS  PubMed  Google Scholar 

  188. Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA (2006) Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 41(5):453–461

    Article  CAS  PubMed  Google Scholar 

  189. Yu W, Simmons-Menchaca M, Gapor A, Sanders BG, Kline K (1999) Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 33(1):26–32

    Article  PubMed  Google Scholar 

  190. Zaiden N, Yap WN, Ong S et al (2010) Gamma delta tocotrienols reduce hepatic triglyceride synthesis and Vldl secretion. J Atheroscler Thromb 17(10):1019–1032

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work is supported by Universiti Kebangsaan Malaysia via grants GGPM-2015-036.

Author information

Authors and Affiliations

  1. Department of Pharmacology, Universiti Kebangsaan Malaysia Medical Centre, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000, Kuala Lumpur, Malaysia

    Kok-Yong Chin & Ima-Nirwana Soelaiman

  2. Biomedical Science Programme, School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Abdul Aziz, 50300, Kuala Lumpur, Malaysia

    Kok-Lun Pang

Authors
  1. Kok-Yong Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kok-Lun Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ima-Nirwana Soelaiman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ima-Nirwana Soelaiman .

Editor information

Editors and Affiliations

  1. Banaras Hindu University , Varanasi, Uttar Pradesh, India

    Subash Chandra Gupta

  2. MD Anderson Cancer Center, University of Texas, Houston, Texas, USA

    Sahdeo Prasad

  3. Anti-Inflammation Research Institute, San Diego, California, USA

    Bharat B. Aggarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chin, KY., Pang, KL., Soelaiman, IN. (2016). Tocotrienol and Its Role in Chronic Diseases. In: Gupta, S., Prasad, S., Aggarwal, B. (eds) Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology, vol 928. Springer, Cham. https://doi.org/10.1007/978-3-319-41334-1_5

Download citation

Publish with us

Policies and ethics

Search

Navigation